IDH2 and glioma: In IDH mutant gliomas, neomorphic enzyme activity generates the 2-HG, which competitively inhibits α-ketoglutarate-dependent dioxygenases (e.g., TET family enzymes), leading to genome-wide DNA hypermethylation, the hallmark of G-CIMP [41].